Related Experiment Video
Updated: Jun 23, 2026
Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
How to predict implantation? No correlation between embryonic aneuploidy and soluble human leukocyte antigen
Carolyn B Coulam1, Roumen G Roussev, Sveltana Lerner
1Rinehart Center for Reproductive Medicine, Evanston, Illinois, USA. cbcoulam@aol.com
Objective:
To determine if soluble human leukocyte antigen-G (sHLA-G) concentrations in spent culture media may assist in identifying the normal embryo for implantation.
Design:
Prospective blinded comparative study.
Setting:
Reproductive genetic and reproductive medicine centers.
Patient(S):
One hundred and sixteen embryos obtained from eight patients undergoing in vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD).
Intervention(S):
Culture media obtained 2 days after fertilization were analyzed for sHLA-G concentrations using an enzyme-linked immunosorbent assay (ELISA) assay. A sHLA-G concentration of >or=1.9 mIU/mL was considered a positive predictor for successful implantation. Polar bodies and blastomeres from day-3 embryos were tested by PGD for 5 to 11 chromosomes: 8, 9, 13, 15, 16, 17, 18, 21, 22, X, and Y.
Main Outcome Measure(S):
The results of the sHLA-G concentrations were compared with the results of the PGD analyses.
Result(S):
We found an sHLA-G concentration >or=1.9 mIU/mL in 48% (56 out of 116) and normal PGD results in 52% (57 out of 116) of embryos. Of the embryos with normal PGD results, 46% (26 out of 57) had sHLA-G concentrations >or=1.9 mIU/mL. Among the embryos with sHLA-G >or=1.9 mIU/mL, 46% (26 out of 56) had normal PGD results, and 21% of embryos displayed both normal PGD results and sHLA-G >or=1.9 mIU/mL.
Conclusion(S):
No correlation between concentrations of sHLA-G in embryo culture media and PGD results of an embryo's aneuploidy were observed.
